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INTRODUCTION
Due to the characteristics of cerebrovascular and heart dis-
ease, the fatality rate of the disease is very high; during treat-
ment, it needs intensive care for a short period of time, which
uses high-priced equipment and expensive medicine, or long-
term treatment. Therefore, the benefits of industrial accident
compensation insurance for cerebrovascular and heart disease
are expected to be higher than those of other occupational dis-
eases. However, the yearly data on the benefits of industrial
accident compensation insurance do not specify the amount of
insurance benefits by industrial accidents; so the expenditure
on work-related cerebrovascular and heart disease cannot be
calculated accurately. As the proportion of work-related cere-
brovascular and heart disease increases (1), the proportion of
its insurance benefits to the total benefits for industrial accident
compensation insurance will increase accordingly. Currently,
80% of industrial accident insurance fund is spent on insurance
benefits (2), and it can greatly affect the management of indus-
trial accident compensation insurance.
Insurance benefits are composed of the following: 1) medical
care benefit (expenses spent on treatment); 2) shutdown ben-
efit (expenses paid for unemployed period due to medical treat-
ment); 3) disability benefit (expenses paid for uncured disabil-
ities after the completion of treatment); 4) injury-disease com-
pensation annuity (expenses paid for workers who have been
diagnosed as incurable cases - the grade 1-3 - even after 2 yr
of treatment); 5) survivors benefit (expenses paid for surviving
family members); and 6) funeral expenses (expenses paid to
people who prepares a funeral. Nursing benefit (expenses paid
for home care even after the completion of medical treatment)
has been recently added to the list.
This study will analyze insurance benefits paid for work-relat-
ed cerebrovascular and heart disease since 1995. Based on the
analysis, the expenditure of industrial accident compensation
insurance will be predicted. So, this study will present the im-
portance of work-related cerebrovascular and heart disease and
the need of its management in terms of medical expenses.
DATA COLLECTION AND METHODS
Data Collection
From the cases of cerebrovascular and heart disease, which
had occurred between January 1, 1995 and December 31,
2000, the insurance benefits paid for the 4,300 cases of cere-
brovascular and heart disease, approved as work-related by the
law of industrial accident compensation insurance as of July
31, 2001, were used as the data for this study.
According to the current treatment status of 4,300 cases, as
of July 31, 2001, there were 275 cases in 1995 (23 open cases,
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Industrial Accident Compensation Insurance Benefits on 
Cerebrovascular and Heart Disease in Korea
The purpose of this study is to present the importance of work-related cerebrovas-
cular and heart disease from the viewpoint of expenses. Using the insurance ben-
efit paid for the 4,300 cases, this study estimated the burden of insurance benefits
spent on work-related cerebrovascular and heart disease. The number of cases
with work-related cerebrovascular and heart disease per 100,000 insured workers
were 3.36 in 1995; they were increased to 13.16 in 2000. By the days of occurrence,
the estimated number of cases were 1,336 in 2001 (95% CI: 1,211-1,460 cases)
and 1,769 in 2005 (CI: 1,610-1,931 cases). The estimated average insurance ben-
efits paid per person with work-related cerebrovascular and heart disease was 75-
19 million won for medical care benefit and 56 million won for other benefits except
medical care. By considering the increase in insurance payment and average pay,
the predicted insurance benefits for work-related cerebrovascular and heart disease
was 107.9 billion won for the 2001 cohort and 192.4 billion won for the 2005 cohort.
From an economic perspective, the results will be used as important evidence for
the prevention and management of work-related cerebrovascular and heart disease.
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Accepted : 2 June 2003106 closed cases, and 128 death cases); and 1,170 cases in 2000
(751 open cases, 97 closed cases, and 322 death cases). Open
case represents the workers who are under care. Closed case
represents the workers who were over care and receive disability
benefits. Death represents the workers who have died from
disease. Insurance benefits such as medical expenses, disability
compensation, and/or funeral expenses are expected to continue
to remain to open cases.
Cerebrovascular disease, which is approved as work-related
disease by the law of industrial accident compensation insur-
ance, includes subarachnoid hemorrhage, intracranial hemor-
rhage, cerebral infarction, and hypertensive cerebropathy.
Heart disease, on the other hand, includes myocardial infarc-
tion, angina pectoris, and aortic dissection.
When there were more than 2 diagnostic names, major dia-
gnostic name was used. Sudden deaths (Karoshi) to those who
had potential risk of cerebrovascular and/or heart disease were
included in this study.
Korea Labor Welfare Corporation is the sole government
agency which handles all work-related compensations in Ko-
rea; it has records of insurance benefits paid to the workers
with work-related diseases from the onset of care to the com-
pletion of care or death. From this data, the accumulated insur-
ance benefits which are paid from the beginning of care to the
completion of care can be calculated.
Estimation of Approved Cases of Work-Related 
Cerebrovascular and Heart Disease
For approved work-related cerebrovascular and heart disease,
6 incidence year cohorts were formulated for the 6-yr period
between 1995 and 2000 based on the occurrence date. As to
the 6 incidence year cohorts, the number of approved cases
of cerebrovascular and heart disease was calculated for every
100,000 insured workers.
A linear regression equation was obtained by using regres-
sion analysis on two variables: 1) the number of approved cases
for every 100,000 insured worker during 6 yr; and 2) the time
(incidence year). Then, the obtained regression equation was
used to predict the anticipated number of incidence cases for
next 5 yr (2001-2005) and the 95% confidence interval (CI)
for the estimated approved cases. The number of insured work-
ers was 9,465,557 in December 2000, and an assumption is
made that the number will increase by 3% annually for the
next 5 consecutive years, as more workers will be eligible for
the benefits by the revision of labor insurance policy in Korea.
Estimation of Insurance Benefits and Analysis of
Sensitivity
Using the cases for which 90% or more insurance benefit
was paid from 1995 to 1997 incidence cohort, the average in-
surance benefit paid per person with work-related cerebrovas-
cular and heart disease could be estimated by differentiating
medical care benefits from other types of benefits.
Medical care benefits were estimated based on the insurance
payment, whereas other benefits excluding medical care ben-
efit were calculated based on the average pay. Increase rates for
these two benefits were calculated by considering increase rates
of insurance payment and average pay. For the last 10 yr, the
increase rate of 7.5% for insurance payment and 7.8% for an-
nual average pay of manufacturing industries was applied. The
insurance benefits for work-related cerebrovascular and heart
disease were calculated as follows:
In addition, expenditure of insurance benefits can be fluctu-
ated by the changes in the following factors: 1) average insur-
ance benefits per person; 2) predicted incidence cases; 3) incre-
ase rate of insurance payment; and 4) increase rate of average
pay. The analysis of sensitivity to these factors was performed
to predict the range of estimated insurance benefits.
In the analysis of sensitivity, the following rates for the factors
were used: 1) to predict average insurance benefits per person,
used 10% of average insurance benefits per person was applied;
2) to predict incidence cases, used 95% CI of estimated inci-
dence cases was applied; 3) for increase rate of insurance bene-
fits, used 10% of increase rate of insurance payment obtained
from last 10 yr was applied; and 4) for increase rate of average
pay, use 10% of increase rate of average pay obtained from the
last 10 yr was applied.
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Total expenditureyear=Mean amount of medical care bene-
fits * Nyear * (1+△i year)+Mean amount of other benefits
except medical care * Nyear * (1+△jyear)
Total expenditureyear: Total insurance benefits for work-relat-
ed cerebrovascalur cerebrovascular and heart disease
occurred at designated time
Mean amount of medical care benefits: Average medical care
benefit
Mean amount of other benefits except medical care: Aver-
age other insurance benefits excluding medical care
expenses
Nyear: Number of approved cases of work-related cerebrovas-
cular and heart disease at designated time
△iyear: Annual increase rate for insurance payment
△jyear: Annual increase rate for average pay
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Fig. 1. Estimation of approved cases per 100,000 insured workers
for work-related cerebrovascular and heart disease.
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Data Analysis
A statistical package, SAS (6.12 version), was used to ana-
lyze the data. A regression equation of time (incidence year)
against the number of incidence cases of work-related cere-
brovascular and heart disease were obtained. The results of
the analysis on insurance benefits for work-related cerebrovas-
cular and heart disease were used to predict the insurance
benefits for the future years.
RESULTS
Estimation of Approved Cases of Work-Related Cere-
brovascular and Heart Disease
Based on the day of occurrence, the approved cases of work-
related cerebrovascular and heart disease were increasing annu-
ally for every 100,000 insured workers, from 3.36 in 1995 to
13.16 in 2000; increasing rate of the approved cases of work-
related cerebrovascular and heart disease, on the other hand,
were decreasing every year for every 100,000 insured workers
from 3.66 in 1996 to 0.97 in 2000 (Fig. 1).
From 1995 to 2000, the regression equation of time (inci-
dence year) against the number of incidence cases of cerebrova-
scular and heart disease for every 100,000 insured workers for
a designated corresponding year was:
The incidence cases of cerebrovascular and heart disease bet-
ween 2001 and 2005 predicted by the regression equation are
expected to increase from 13.7 in 2001 (95% CI: 12.4-15.0)
to 16.1 in 2005 (95% CI: 14.6-17.6) for every 100,000 insur-
ed workers; whereas the increasing rate will be decreased as
time goes (Fig. 1). And the predicted number of incidence
cases of cerebrovascular and heart disease for the next 5 yr were
1,336 cases for 2001 (95% CI: 1,211-1,460 cases) and 1,769
cases for 2005 (95% CI: 1,610-1,931 cases) (Table 2).
Estimation of Average Insurance Benefit per Person
In 1995 cohort, the average insurance amount was 146 mil-
lion won for the open cases, 68 million won for the closed cases,
and 72 million won for the deaths. And in 2000 cohort, the
average insurance amount was 16 million won for the open
Yyear=5.38 * ln(Xyear) + 3.20
Yyear: Approved incidence cases of cerebrovascular and heart
disease for every 100,000 insured workers in the year
Y
Xyear: Coding for each year (1995=1; 2000=6; 2001=7;
2005=11)
Open case 23 46 111 207 380 751
Closed case 106 273 284 242 203 97
Death 128 235 313 284 295 322
Total 257 554 708 733 878 1,170
Cohort 1995 1996 1997 1998 1999 2000
Table 1. Distribution of the 1995-2000 cohorts by current treatment
status
Open case represents the workers, who are proven to have work-relat-
ed cerebrovascular or heart disease, and are under care. Closed case
represents the workers, who were proven to have work-related cere-
brovascular or heart disease, were over care and received disability
benefits. Death represents the workers, who were proven to have work-
related cerebrovascular or heart disease, died from the disease.
2001 9,770,120 13.7 12.4-15.0 1,211-1,460
2002 10,063,227 14.4 13.1-15.7 1,314-1,560
2003 10,365,124 15.0 13.7-16.4 1,415-1,698
2004 10,676,078 15.6 14.2-17.0 1,513-1,814
2005 10,996,360 16.1 14.6-17.6 1,610-1,931
Cohort
Insured
workers
Approved
case
per 100,000
workers
95% CI for
approved case
per
100,000
workers
95% CI for work-
related
cerebrovascular
and
heart disease
Table 2. Forecasting cases of work-related cerebrovascular and
heart disease for 2001-2005 cohorts
Mean expenditure 77 70 71 66 48 33
Open case 146 113 95 65 35 16
Closed case 68 53 51 42 33 25
Death 72 83 80 86 75 73
Cohort 1995 1996 1997 1998 1999 2000
Table 3. Mean expenditure per person for the 1995-2000 cohorts
by current treatment status (Unit: million won)
Mean expenditure represents benefits per person which was given by
Industrial Accident Compensation Insurance i.e. medical care benefit,
shutdown benefit, disability benefit, survivors benefit, funeral expenses,
and injury-disease compensation annuity. Open case represents the
workers, who are proven to have work-related cerebrovascular or heart
disease, are under care. Closed case represents the workers, who
were proven to have work-related cerebrovascular or heart disease,
were over care and received disability benefits. Death represents the
workers, who were proven to have work-related cerebrovascular or
heart disease, died from the disease.
Open case 3,364 5,179 10,494
+benefits will be added * +736 +1,472 +3,552
Closed case 7,248 14,405 14,524
Death 9,164 19,408 25,110
Total expenditure 20,512 40,464 53,679
Mean expenditure per capita 80 73 76
Cohort
(No.)
1995
(257)
1996
(554)
1997
(708)
Table 4. Estimated mean expenditure per person (Unit: million
won)
*: Open case represents any incomplete compensation that requires
more spending such as medical care, disability benefits, and/or funer-
al expenses in the case of death.486 H.S. Kim, J.W. Choi, S.H. Chang, et al. 
cases, 25 million won for the closed cases, and 73 million won
for the deaths (Table 3).
For the death and closed cases with disability, an average of
32 million won per person was paid for the disability benefit,
funeral expense, survivors benefit, and injury-disease benefit.
Therefore, if additional 32 million won was paid to workers
who were under care (open case) due to death or disability, the
average insurance benefit per person would be: 80 million
won for the 1996 incidence cohort, 73 million won for the
1996 incidence cohort, and 76 million won for the 1997 inci-
dence cohort (Table 4). By using 3 data of incidence cohorts,
the estimated average insurance benefit per person was 75 mil-
lion won; out of this benefit, 19 million won was for medical
care benefit and 56 million won was for other insurance benefit
except medical care benefit.
Estimation of Insurance Benefit for Future Years
The necessary insurance benefit for the 265 cases of the year
1995 cohort was 19.87 billion won; whereas, for 1,248 cases of
the 2000 cohort, it was 93.6 billion won. Considering the in-
crease rates in insurance payment and average page, it was esti-
mated that 107.9 billion won would be needed for the 2001
cohort, and 192.4 billion won for the 2005 cohort (Table 5).
After the sensitivity analysis, the predicted range of insur-
ance benefit was 87.4-130.7 billion won for the 2001 inciden-
ce cohort and 152.1-239.5 billion won for the 2005 incidence
cohort (Table 6).
DISCUSSION
According to the human capital method and the incidence-
based approach, the estimation of expenditure for this study
is limited to the industrial accident compensation insurance
benefits that the Korea Labor Welfare Corporation actually
paid for work-related cerebrovascular and heart disease.
Human capital method excludes intangible value of human
and depends solely on income. So the disadvantage of this me-
thod is to estimate expenses too low for low-income groups
such as women, young teens, or old generation in labor market
(3). Nevertheless, the reason that this method is widely used
is because the collection of data to estimate expenses is relative-
ly easy, and it can quantify the following factors clearly: 1) the
direct expenses for the prevention of disease, diagnosis, treat-
ment, and rehabilitation; 2) the value of lost productivity from
disease; or 3) reduced future income based on the income level
from the starting point.
Human capital approach can be further divided into the in-
cidence-based approach and the prevalence-based approach.
The incidence-based approach is to estimate direct and indirect
expenses needed for remaining average life span of a worker
since the suffering of disease. As the value of currency changes
as time goes, the total expenses for the remaining life are ad-
justed for current value by using discount rate. This method
1995 265 19 5,035 56 14,840 19,875
1996 573 19 10,887 56 32,088 42,975
1997 727 19 13,813 56 40,172 53,985
1998 760 19 14,440 56 42,560 57,000
1999 907 19 17,233 56 50,792 68,025
2000 1,248 19 1.00 23,712 56 1.00 69,888 93,600
2001 1,336 19 1.07 27,288 56 1.08 80,652 107,940
2002 1,447 19 1.15 31,772 56 1.17 94,166 125,940
2003 1,557 19 1.24 36,751 56 1.26 109,228 145,979
2004 1,663 19 1.33 42,197 56 1.36 125,764 167,961
2005 1,769 19 1.43 48,253 56 1.47 144,215 192,468
Cohot
Size of
cohort
Total
Expenditure
(1)+(2)*
Medical care benefits
Other benefits
(Except medical care)
Table 5. Expected total expenditure for the 1995-2005 cohorts
A: Medical care benefits per person (million won), B: Increased rate of cost of medical insurance, C: Other benefits per person (million won), D:
Increased rate of wage. *: million won.
A B (1)* C D (2)*
1995 265 75 19.9
1996 573 75 43.0
1997 727 75 54.0
1998 760 68 - 83 51.3-62.7
1999 907 68 - 83 61.2-74.8
2000 1,248 68 - 83 1.00 1.00 84.2-103.0
2001 1,211-1,460 68 - 83 1.07-1.08 1.07-1.08 87.4-130.7
2002 1,314-1,560 68 - 83 1.11-1.17 1.15-1.18 100.9-151.5
2003 1,415-1,698 68 - 83 1.23-1.27 1.23-1.28 116.8-178.9
2004 1,513-1,814 68 - 83 1.30-1.37 1.31-1.38 133.6-207.3
2005 1,610-1,931 68 - 83 1.39-1.49 1.40-1.51 152.1-239.5
Cohort
Size of
cohort
Mean
expenditure
per capita*
Medical
insurance
cost
�
Wage
�
Range of
expected total
expenditure
�
Table 6. Sensitivity analysis of total expenditure for the 1998-2005
cohorts
*: million won, 
� : increased rate, 
� : billion won.can convert all economic burdens into expenses, and it is usu-
ally used to evaluate the effectiveness of prevention program
of occupational disease (4). The prevalence-based approach is
to estimate direct and indirect expenses needed by disease dur-
ing a fixed time, usually by calendar years. It estimates the fol-
lowing : 1) the expenses of exhausted resources by disease, 2)
converted expenses of reduced productivity affected by disease,
the disability or death--during the fixed time; and then it re-
evaluates to current value by using discount rate (5).
Usually, the statistics on industrial accident compensation
insurance are reported based on the approval date of care, and
so there is time difference between the real occurrence date of
work-related industrial accident/disease and the approval date
of care. Especially, in the case of cerebrovascular and heart dis-
ease, the time difference between the onset of disease and the
approval date of care is 1 to 2 yr or more in many cases. The
reason for the difference is that the statistics of work-related
cerebrovascular and heart disease published by the Ministry of
Labor reflect the data at around the approval date of work-relat-
ed disease, rather than the data of the occurrence of disease.
Therefore, if research was conducted with data based on the
approval date of care, the results of research would not reflect
the yearly work-related cerebrovascular and heart disease; if
this is the case, it is impossible to predict the magnitude of
occurrences and the expenditure of benefits. To remove this
confounding factor, this study calculated the number of cere-
brovascular and heart cases from the date of occurrence, not
from the approval date of care.
The predicted cases of work-related cerebrovascular and heart
disease were estimated to be 1,336 cases in 2001 (95% CI:
1,211-1,460 cases) and 1,769 cases in 2005 (95% CI: 1,610-
1,931 cases). The predicted cases for future years in this
research are the results of the analysis of the trends of work-
related cerebrovascular and heart disease, which is based on a
group of insured workers for the last 6 yr.
When the number of work-related disease cannot be obtain-
ed accurately, the method of proportionate attributable risk
is usually used to estimate the number of work-related disease
cases. This method is based on the hypothesis that the occur-
rences of disease are partly attributable to work. For example,
about the work-related cerebrovascular and heart disease and
death, Leigh et al. (6) attributed to work only 1-10% and Mar-
kowitz et al. (7) and Kraut (8) 1-3%. Karasek and Theorell
(9) estimated work-related cerebrovascular and heart disease
by applying 9-13% for men and 3-7% for women. In the case
of Korea, from the comparison of the estimated occurrences
of cerebrovascular disease from the trial observation system by
the Ministry of Health and Welfare (10) and the results of this
study on the work-related cerebrovascular and heart disease,
it can be concluded that 3.3% of cerebrovascular and heart
disease can be attributable to work.
According to data obtained from 1995, 1996, and 1997 in-
cidence cohorts, average insurance benefit per person was esti-
mated to be 75 million won; medical care benefit was 19 mil-
lion and other benefits except medical care benefit was 56 mil-
lion. At the completion of treatment, if there is a determina-
tion of disability, the disability benefit was close to the sum
of medical care benefits and shutdown benefit. In the case of
death, most of the benefits were for surviving family benefits
and funeral expenses.
Finally, the estimated insurance benefit for work-related cere-
brovascular and heart disease was 43 billion won for 1996 inci-
dence cohort and 93.6 billion for the 2000 incidence cohort;
the results show that, besides the currently paid insurance ben-
efits, the additional 4 billion won and 55.4 billion won is need-
ed for the respective cohorts. Also, for the 2001 incidence co-
hort and the 2005 incidence cohort, 107.9 billion won (95%
CI: 87.4-130.7 billion) and 192.5 billion won (95% CI: 152.1-
239.5 billion) will be needed for insurance benefits, respective-
ly. The results show that, as time goes, insurance benefits for
the cerebrovascular and heart disease will be increased.
Estimates of the economic cost of occupational disease have
at least two purposes. First, economic estimates can play a role
in informing the political and administrative decision-making
processes which shape occupational health policy. Second, eco-
nomic estimates can illuminate value judgments. Public and
private responsibility for workers health is diffused, when the
assumptions that underlie industrial health policies remain
implicit. Economic analyses can make those assumptions ex-
plicit through contrasting the benefits and costs of alternative
occupational health policies. For theses two reasons, economic
analysis can be used as a tool to encourage rational health and
labor policies (5).
Since the 1990s, the proportion of the insurance benefits
spent on work-related cerebrovascular and heart disease to the
total fund of industrial accident compensation insurance is ex-
pected to increase annually in consideration of rapidly increas-
ing number of suffering patients and death due to work-related
cerebrovascular and heart disease. This research presents con-
crete evidence for the burden of expenses. The average accumu-
lated insurance benefits per workers with work-related cere-
brovascular and heart disease were estimated to be 75 million
won. The results of this study show that the increase in medical
expenses, average pay, and the number of disasters will lead to
the increase of insurance benefits for work-related cerebrovas-
cular and heart disease. The necessary insurance benefits for
the 2000 incidence cohort were 93.6 billion won, which has
increased 4.7 times more compared to 19.9 billion won for the
1995 incidence cohort.
Countries of similar standards with Korea, regarding work-
related cerebrovascular and heart disease, are Japan and Taiwan
(11). In the cases of Europe or America, there is some difference
in the standards of industrial accident compensation insurance
in each country or state; therefore, not every work-related cere-
brovascular and heart disease receives benefits (12).  Also there
are not many studies done on expenditure of cerebrovascular
and heart disease by country or state unit. Fahs et al. (5) calcu-
lated the expenses spent on death due to work-related asymp-
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New York City in 1985. The total expenses for asymptomatic
coronary heart disease were U$47,281-U$11,219 for direct
expenses and U$36,062 for indirect expenses; the total expens-
es for cerebrovascuar disease were U$58,518-U$24,413 for
direct and U$34,105 for indirect expenses.
The limitations of this research are as follows: 1) In the esti-
mation of expenses, the actual number of cohorts and predicted
cases are tricky. In this research, a regression equation reflecting
the changes in incidence cases for the last 6 yr and the number
of predicted cases were estimated under the assumption that
the number of eligible workers for the benefits would increase
consistently at the rate of 3% and the decreasing rate of work
related cerebrovascular and heart disease would maintain its
trend. At present, this approach is considered to be the best
in estimating the number of cases for work-related cerebrovas-
cular and heart disease, and the limitation will be overcome
through continuous collection of data. 2) As to the factors
affecting the expenses of work-related cerebrovascular and
heart disease, the increases in medical insurance payment, aver-
age pay, and approved cases were considered in this research.
The intensity of medical service, the amount of medical service
use, the benefit range, the approval standard for work-related
industrial disease, and the financial situation of industrial acci-
dent compensation insurance can also affect benefits. However,
since there are no data available for the intensity of medical
service, the amount of medical service use, or the benefit range
in the area of industrial accident compensation insurance, it
is not easy to obtain those data. So this study used insurance
benefit data only. 3) Finally, insurance benefits on work-related
cerebrovascular and heart disease by incidence cohorts in this
study are accumulated expenses from the occurrence date to
the completion of care including the expenses for disability or
death. Whereas the total industrial accident insurance benefits,
which are reported by the Korea Labor Welfare Corporation
as annual report show only the total yearly expenses for each
calendar year. As a result, no direct comparisons can be made
between these two sets of data. When the Korea Labor Welfare
Corporation reports the usage of industrial accident compensa-
tion insurance fund yearly, insurance benefit data should be
presented by types of industrial accidents, which includes occu-
pational diseases, to forecast more accurate insurance benefits.
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